BioXcel Therapeutics
BTAI
BTAI
41 hedge funds and large institutions have $5.66M invested in BioXcel Therapeutics in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.44% more ownership
Funds ownership: 14.73% → 16.17% (+1.4%)
6% less capital invested
Capital invested by funds: $6.05M → $5.66M (-$391K)
Holders
41
Holding in Top 10
–
Calls
$7K
Puts
$5K
Top Buyers
| 1 | +$1.66M | |
| 2 | +$263K | |
| 3 | +$248K | |
| 4 |
Jones Financial Companies
Des Peres,
Missouri
|
+$210K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$208K |
Top Sellers
| 1 | -$290K | |
| 2 | -$223K | |
| 3 | -$75.6K | |
| 4 |
SH
SLT Holdings
Scottsdale,
Arizona
|
-$75.5K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$24.7K |
